DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
DRG and its group companies would like to inform you that we have updated our website privacy policy.
Gauge the commercial outlook for new brands, generics and other key market events
Review current treatments, assess unmet needs and corresponding opportunities and profile emerging therapies
180+ indications in therapy areas including oncology, rare diseases, cardiovascular and more. To view indication specific research click here.
Methodology
Based on DRG’s epidemiology, KOL interviews and DRG expert opinion
Annualized, bottom-up 10-year forecasts for the G7 segmented by class, brand/generic and population
Updated quarterly based on regulatory, clinical and market events
Solution Feature Enhancement
Market Forecast Dashboard provides enhanced data-mining capabilities with auto-generated charts and figures to create customized views based on specific populations, geographies, drugs/ drug classes and more.
Want to learn more?
Contact us to connect with a DRG specialist on how we can help you get actionable insights to optimize long-term disease strategy